IKZF1 and UBR4 gene variants drive autoimmunity and Th2 polarization in IgG4-related disease
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci178692 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Qingxiang Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology. Hauptthemen laut MEDLINE: Autoimmunity, Ikaros Transcription Factor, Th2 Cells, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
IgG4-related disease (IgG4-RD) is a systemic immune-mediated fibroinflammatory disease whose pathomechanisms remain poorly understood. Here, we identified gene variants in familial IgG4-RD and determined their functional consequences. All 3 affected members of the family shared variants of the transcription factor IKAROS, encoded by IKZF1 , and the E3 ubiquitin ligase UBR4. The IKAROS variant increased binding to the FYN promoter, resulting in higher transcription of FYN in T cells. The UBR4 variant prevented the lysosomal degradation of the phosphatase CD45. In the presence of elevated FYN, CD45 functioned as a positive regulatory loop, lowering the threshold for T cell activation. Consequently, T cells from the affected family members were hyperresponsive to stimulation. When transduced with a low-avidity, autoreactive T cell receptor, their T cells responded to the autoantigenic peptide. In parallel, high expression of FYN in T cells biased their differentiation toward Th2 polarization by stabilizing the transcription factor JunB. This bias was consistent with the frequent atopic manifestations in patients with IgG4-RD, including the affected family members in the present study. Building on the functional consequences of these 2 variants, we propose a disease model that is not only instructive for IgG4-RD but also for atopic diseases and autoimmune diseases associated with an IKZF1 risk haplotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology.
- Department of Medicine.
- Center for Individualized Medicine and Department of Clinical Genomics, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
- Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIAMS NIH HHS
- NIA NIH HHS
- NIAID
- NIAMS
Zitieren
APA
Liu, Q., Zheng, Y., Sturmlechner, I., Jain, A., Own, M., Yang, Q., Zhang, H., Pinto E Vairo, F., Cerosaletti, K., Buckner, J. H., Warrington, K. J., Koster, M. J., Weyand, C. M., & Goronzy, J. J. (2024). IKZF1 and UBR4 gene variants drive autoimmunity and Th2 polarization in IgG4-related disease. Journal of Clinical Investigation. https://doi.org/10.1172/jci178692
Vancouver
Liu Q, Zheng Y, Sturmlechner I, Jain A, Own M, Yang Q, et al. IKZF1 and UBR4 gene variants drive autoimmunity and Th2 polarization in IgG4-related disease. Journal of Clinical Investigation. 2024. doi:10.1172/jci178692
BibTeX
@article{Liu2024,
author = {Liu, Qingxiang and Zheng, Yanyan and Sturmlechner, Ines and Jain, Abhinav and Own, Maryam and Yang, Qiankun and Zhang, Huimin and Pinto E Vairo, Filippo and Cerosaletti, Karen and Buckner, Jane H and Warrington, Kenneth J and Koster, Matthew J and Weyand, Cornelia M and Goronzy, Jörg J},
title = {IKZF1 and UBR4 gene variants drive autoimmunity and Th2 polarization in IgG4-related disease},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci178692}
}
EUVIMED